Mounjaro Medical Weight Loss
Weekly Mounjaro injections help support your weight loss goals.
Available in: Injections
FDA Approved - FDA-approved for type 2 diabetes risks, prescribed off-label for weight management.
Reduced Cravings - Decreases appetite and slows digestion so you feel full longer.
Improved Metabolic Health - Improves how your body responds to sugars for better blood sugar control.
Long-Term Weight Management - Targets GLP-1 and GIP receptors to maximize sustained weight loss.
Mounjaro is the brand-name version of tirzepatide, a dual-action GLP-1 receptor agonist with FDA approval for managing certain risks of type 2 diabetes. It targets both GLP-1 and GIP pathways, giving providers an off-label option for patients who need broader metabolic support alongside weight management.
Mounjaro is the brand-name version of tirzepatide, a dual-action medication that works through both GLP-1 and GIP receptors. It is FDA-approved for managing certain risks of type 2 diabetes and may also be prescribed off-label to support weight management.
Mounjaro helps you lose weight by decreasing appetite and slowing the movement of food from the stomach into the small intestine, so you feel full faster and for longer. It targets two hormone receptors (GLP-1 and GIP) to maximize weight loss.
Add-ons
The services provided have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any treatment or therapy program. Any designations or references to therapies are for marketing purposes only and do not represent actual products.